c) If the patient were on aspirin or with a previous history of CAD he would benefit from IIb/IIIa inhibitors

Probably

Based on the PRISM-PLUS study these patients did better with IIb/IIIa inhibitors than those without the above co-morbid disease. People that also showed improvement were those with prior CABG, elderly, ST depression on EKG and ß-blocker use (14)

There may be more than one correct answer for this decision point.